The application of prescribing indicators to a primary care prescription database in Ireland

European Journal of Clinical Pharmacology

Volumn 61, Issue 2, 2005, Pages 127-133

  Williams, D ^a   Bennett, K ^b   Feely, J ^b  

^a ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^b ST JAMES S HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANOREXIGENIC AGENT; ANTIBIOTIC AGENT; ANXIOLYTIC AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; COTRIMOXAZOLE; DICLOFENAC; GENERIC DRUG; HORMONE; HYPNOTIC SEDATIVE AGENT; IBUPROFEN; INDOMETACIN; NAPROXEN; NITRATE; NONSTEROID ANTIINFLAMMATORY AGENT; PERIPHERAL VASODILATING AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULFONYLUREA; TRIMETHOPRIM; VASODILATOR AGENT;

CONTROLLED STUDY; DATA BASE; DRUG EFFICACY; DRUG SAFETY; FEMALE; GENERAL PRACTITIONER; HEALTH SURVEY; HUMAN; IRELAND; MALE; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REVIEW;

DATABASES, FACTUAL; DRUG UTILIZATION REVIEW; FAMILY PRACTICE; HUMANS; IRELAND; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; QUALITY INDICATORS, HEALTH CARE;

EID: 18744414215     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-004-0876-3     Document Type: Review

References (33)

1. Lawrence M, Olesen F (1997) Indicators of quality in health care. Eur J Gen Pract 3:103
2. Cantrill J, Sibbald B, Buetow S (1998) Indicators of the appropriateness of long term prescribing in general practice in the United Kingdom: consensus development, face and content validity, feasibility, and reliability. Qual Health Care 7:130
3. Audit Commission (1994) A prescription for improvement; towards more rational prescribing in general practice. HMSO
4. Feely J (1992) The influence of pharmacoeconomic factors on prescribing patterns in Ireland. Pharmacoeconomics 2:99
5. General Medical Services (Payments) Board (2000) Report for the year ended 31st December
6. Bateman DN, Eccles M, Campbell M, Soutter J, Roberts SJ, Smith J (1996) Setting standards of prescribing performance in primary care: use of a consensus group of general practitioners and application of standards to practices in the north of England. Br J Gen Pract 46:20
7. Thomas S, Campbell M (1996) Utilisation of appetite suppressants in England: a putative indicator of poor prescribing practice. Pharmacoepidemiol Drug Saf 5:237
8. Campbell SM, Roland MO, Qualye JA, Shekelle PG, Buetow S (1998) Quality indicators for General Practice; Which ones can general practitioners and health authority managers agree are important and how useful are they? J Public Health Med 20:414
9. Campbell S, Cantrill J, Roberts D (2002) Prescribing indicators for UK general practice: Delphi consultation study, BMJ 21:1
10. Oborne A, Batty G, Maskrey V, Swift C, Jackson S (1997) Development of prescribing indicators for elderly medical inpatients. Br J Clin Pharmacol 43:91
11. Lawton B, Rose S, McLeod D, Dowell A (2003) Changes in use of hormone replacement therapy after the report from the Women's Health Initiative: cross sectional survey of users. BMJ 327:845
12. Connolly HM, Crary JL, McGoon MD, Hensrud DD, Edwards BS, Edwards WD, Schaff HV (1997) Valvular heart disease associated with fenfluramine- phentermine. N Engl J Med 337:581
13. Johnson Z, Hayes C, Dack P (1997) The standardised prescribing ratio - a new method for comparing prescribing between GPs, controlling for patient age and sex. Pharmacoepidemiol Drug Saf 6:337
14. WHO Collaborating Centre for Drug Statistics Methodology (1996) Guidelines For DDD. Oslo
15. Roland M, Holden J, Campbell S (1999) Quality Assessment for General Practice. National Primary Care Research and Development Centre
16. Avery AJ, Heron T, Lloyd D, Harris CM, Roberts D (1998) Investigating relationships between a range of potential indicators of general practice prescribing: an observational study. J Clin Pharm Ther 23:441
17. Collier J (1988) The cases for and against prescribing generic drugs: generic prescribing benefits patients. BMJ 297:1596
18. Walley T, Burrill P (2000) Generic prescribing: time to regulate the market? BMJ 320:131
19. McGettigan P, McManus J, O'Shea B, Chan R, Feely J (1997) Low rate of generic prescribing in the Republic of Ireland compared to England and Northern Ireland: prescribers' concerns. Ir Med J 90:146
20. Moore R, Tramer M, Carroll D, Wiffen P, McQuay H (1998) Quantitive systematic review of topically applied non-steroidal anti-inflammatory drugs. BMJ 316:333
21. Vries Tde, Henning R, Hogerzeil H, Fresle D (1994) Guide to good prescribing. A practical manual. World Health Organisation Action Programme on essential drugs. World Health Organisation, Geneva
22. Henry D, Lim L, Garcia Rodriguez L, Perez Gutthann S, Carson J, Griffin M et al (1996) Variability in risk of gastrointestinal complications with individual non-steroidal antiinflammatory drugs: results of a collaborative metanalysis. BMJ 312:1563
23. Hernandez-Diaz S, Garcia Rodriguez L (2000) Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding/perforation. An overview of epidemiologic studies published in the 1990s. Arch Intern Med 160:2093
24. Robertson J, Fryer J, O'Connell D, Smith A, Henry D (2001) Personal formularies: an index of prescribing quality? Eur J Clin Pharmacol 57:333
25. Harris C, Fry J, Jarman B, Woodman E (1985) Prescribing - a case for prolonged treatment. J R Coll Gen Pract 35:284
26. O'Connell D, Henry D, Tomlins R (1999) Randomised controlled trial of effect of feedback on general practitioners' prescribing in Australia. BMJ 318:507
27. Lagerlov P, Loeb M, Andrew M, Hjortdahl P (2000) Improving doctors' prescribing behaviour through reflection on guidelines and prescription feedback: a randomised controlled study. Qual Health Care 9:159
28. Gehlbach S, Wilkinson W, Hammond W (1984) Improving drug prescribing in a primary care practice. Med Care 22:193
29. Hershey C, Porter D, Breslau D, Cohen D (1986) Influence of simple computerised feedback on prescription charges in an ambulatory clinic. Med Care 24:472
30. Majeed FA, Voss S (1995) Performance indicators for general practice. BMJ 311:209
31. Barnes P, Pedersen S, Busse W (1998) Efficacy and safety of inhaled corticosteroids: new developments. Am J Respir Crit Care Med 157:81
32. Barnes PJ (2000) Chronic obstructive pulmonary disease. N Engl J Med 343:269
33. Halligan A, Donaldson L (2001) Implementing clinical governance: turning vision into reality. BMJ 322:1413